Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;12(7):848-858.
doi: 10.1002/ueg2.12604. Epub 2024 Jun 14.

Expert assessment of infiltration depth and recommendation of endoscopic resection technique in early Barrett cancer

Affiliations

Expert assessment of infiltration depth and recommendation of endoscopic resection technique in early Barrett cancer

Fadi Younis et al. United European Gastroenterol J. 2024 Sep.

Abstract

Background: Early Barrett cancer can be curatively treated by endoscopic resection. The choice of the resection technique, however-endoscopic mucosal resection (EMR) or submucosal dissection (ESD)-largely depends on the assumed infiltration depth as judged by the endoscopist. However, the accuracy of endoscopic diagnosis of the degree of cancer infiltration is not known.

Methods: Three to four high-quality images (both in overview and close-up) from 202 of early Barrett esophagus cancer cases (82% men, mean age 66.9 years) were selected from our endoscopy database (73.3% stage T1a and 26.7% in stage T1b). Images were shown to 9 Barrett esophagus experts, with patients' clinical data (age, sex, Barrett esophagus length) and biopsy results. The experts were asked to predict infiltration depth (T1b vs. T1a), and to suggest the appropriate endoscopic resection technique (EMR or ESD, or surgery). Interobserver variability (kappa values) was also determined for these parameters.

Results: Overall positive (PPV) and negative predictive values (NPV) to diagnose T1b versus T1a infiltration were 40.7% (95% CI: 36.7, 44.8) and 79.8% (95% CI: 77.5, 81.9), respectively; kappa value was 0.41. Paris classification (kappa 0.51) and suggested treatment also varied between experts. In a post hoc analysis, only the correlation between lesions classified as invisible or flat according to the Paris classification (IIB; 25% of all cases) and the suggested resection technique was better: In this subgroup, EMR was recommended in >80% of cases, with a high complete (basal R0) resection rate (mean of 88.1%).

Conclusions: Precise endoscopic distinction between mucosal and submucosal involvement of Barrett esophagus cancer by experts as a basis for choosing the resection technique has limited predictive values and high interobserver variability. It seems that mainly invisible/flat lesions may result in good resection outcomes when treated by EMR, but this stratification strategy has to be assessed in further studies.

Keywords: Barrett esophagus; early cancer; endoscopic resection; interobserver variability; staging.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
Examples of two different lesions resected with endoscopic submucosal dissection. Upper row shows three different lesion images of mucosal cancer (T1a), lower row shows three different lesion images of submucosal invasive cancer (T1b).
FIGURE 2
FIGURE 2
Sensitivity, specificity and interobserver agreement (kappa) for the prediction of infiltration depth using two definitions/cutoffs (see text): T1b versus T1a (upper graph) and T1b ≥ sm2 versus Tbsm1/T1a.
FIGURE 2
FIGURE 2
Sensitivity, specificity and interobserver agreement (kappa) for the prediction of infiltration depth using two definitions/cutoffs (see text): T1b versus T1a (upper graph) and T1b ≥ sm2 versus Tbsm1/T1a.
FIGURE 3
FIGURE 3
Suggested lesion treatment by endoscopic submucosal dissection (in comparison to endoscopic mucosal resection as reference) by experts in correlation with lesion morphology as assessed by the experts.

References

    1. Sharma P. Barrett esophagus: a review. JAMA. 2022;328(7):663–671. 10.1001/jama.2022.13298 - DOI - PubMed
    1. Sharma P, Shaheen NJ, Katzka D, Bergman JJ. AGA clinical practice update on endoscopic treatment of barrett's esophagus with dysplasia and/or early cancer: expert review. Gastroenterology. 2020;158(3):760–769. 10.1053/j.gastro.2019.09.051 - DOI - PubMed
    1. Pimentel‐Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European society of gastrointestinal endoscopy (ESGE) guideline—Update 2022. Endoscopy. 2022;54(06):591–622. 10.1055/a-1811-7025 - DOI - PubMed
    1. Fotis D, Doukas M, Wijnhoven BP, Didden P, Biermann K, Bruno MJ, et al. Submucosal invasion and risk of lymph node invasion in early Barrett's cancer: potential impact of different classification systems on patient management. United Eur Gastroenterol J. 2015;3(6):505–513. 10.1177/2050640615581965 - DOI - PMC - PubMed
    1. Dhingra S, Bahdi F, May SB, Othman MO. Clinicopathologic correlations of superficial esophageal adenocarcinoma in endoscopic submucosal dissection specimens. Diagn Pathol. 2021;16(1):111. 10.1186/s13000-021-01169-1 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources